The latest skin cancer and melanoma news
The first randomised phase III clinical trial in stage II melanoma has shown a 35%…
In what has been described as a paradigm shift in the treatment of melanoma, drug…
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), USA,…
Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not…
The mutations that give rise to melanoma result from a chemical conversion in DNA fueled…
Some antibiotics appear to be effective against melanoma. Researchers at KU Leuven, Belgium, examined the…
One of the major challenges in modern cancer therapy is the adaptive response of cancer…
A phase II study led by researchers from The University of Texas MD Anderson Cancer…
Combining chemotherapy and BRAF oncogene inhibitors is a very effective strategy for fighting metastatic melanoma,…
Uveal melanoma, or UM, is a rare and deadly cancer of the eye, and the…